JPWO2019156230A1 - 医療器具およびこれを用いた癒合促進デバイス - Google Patents
医療器具およびこれを用いた癒合促進デバイス Download PDFInfo
- Publication number
- JPWO2019156230A1 JPWO2019156230A1 JP2019571175A JP2019571175A JPWO2019156230A1 JP WO2019156230 A1 JPWO2019156230 A1 JP WO2019156230A1 JP 2019571175 A JP2019571175 A JP 2019571175A JP 2019571175 A JP2019571175 A JP 2019571175A JP WO2019156230 A1 JPWO2019156230 A1 JP WO2019156230A1
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable sheet
- medical device
- hole
- biodegradable
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000004927 fusion Effects 0.000 title claims abstract description 44
- 230000001737 promoting effect Effects 0.000 claims abstract description 24
- 229920001577 copolymer Polymers 0.000 claims description 15
- 229920000954 Polyglycolide Polymers 0.000 claims description 12
- 239000003623 enhancer Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000004633 polyglycolic acid Substances 0.000 claims description 11
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 7
- 239000004626 polylactic acid Substances 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 34
- 238000001356 surgical procedure Methods 0.000 abstract description 18
- 238000010586 diagram Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 description 32
- 238000012986 modification Methods 0.000 description 32
- 229920006167 biodegradable resin Polymers 0.000 description 19
- 210000003238 esophagus Anatomy 0.000 description 17
- 230000003872 anastomosis Effects 0.000 description 12
- 239000000835 fiber Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 238000001523 electrospinning Methods 0.000 description 8
- 210000001630 jejunum Anatomy 0.000 description 8
- 210000003815 abdominal wall Anatomy 0.000 description 7
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 5
- -1 Polyethylene carbonate Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 229920000515 polycarbonate Polymers 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 229940022769 d- lactic acid Drugs 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 4
- 210000000277 pancreatic duct Anatomy 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 230000000451 tissue damage Effects 0.000 description 4
- 231100000827 tissue damage Toxicity 0.000 description 4
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 229930182843 D-Lactic acid Natural products 0.000 description 3
- 229920001710 Polyorthoester Polymers 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229920003232 aliphatic polyester Polymers 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229960001860 salicylate Drugs 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 238000011902 gastrointestinal surgery Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 210000004303 peritoneum Anatomy 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 239000002745 poly(ortho ester) Substances 0.000 description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- JJTUDXZGHPGLLC-ZXZARUISSA-N (3r,6s)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-ZXZARUISSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000010041 electrostatic spinning Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 229920005586 poly(adipic acid) Polymers 0.000 description 1
- 229920000117 poly(dioxanone) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002961 polybutylene succinate Polymers 0.000 description 1
- 239000004631 polybutylene succinate Substances 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920000921 polyethylene adipate Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B17/1114—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of the digestive tract, e.g. bowels or oesophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07292—Reinforcements for staple line, e.g. pledgets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00597—Implements comprising a membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00884—Material properties enhancing wound closure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00951—Material properties adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0495—Reinforcements for suture lines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B2017/1132—End-to-end connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B2017/1135—End-to-side connections, e.g. T- or Y-connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
上述したように、本発明の一形態は、複数の貫通孔が形成された生分解性シートを備える医療器具であって、前記貫通孔のピッチPに対する孔径Dの比の値(D/P)が0.25以上40未満である、医療器具に関する。本形態に係る医療器具によれば、吻合部(縫合部)に挟み込むという簡便な手法により、外科手術等の術後における縫合不全のリスクを低減させることが可能となる。以下では、本形態についてより詳細に説明する。
生分解性シートの構成材料について特に制限はなく、例えば、生分解性樹脂が挙げられる。生分解性樹脂としては、例えば、特表2011−528275号公報、特表2008−514719号公報、国際公報第2008−1952号、特表2004−509205号公報等に記載されるものなどの公知の生分解性(共)重合体が使用できる。具体的には、(1)脂肪族ポリエステル、ポリエステル、ポリ酸無水物、ポリオルソエステル、ポリカーボネート、ポリホスファゼン、ポリリン酸エステル、ポリビニルアルコール、ポリペプチド、多糖、タンパク質、セルロースからなる群から選択される重合体;(2)上記(1)を構成する一以上の単量体から構成される共重合体などが挙げられる。すなわち、生分解性シートは、脂肪族ポリエステル、ポリエステル、ポリ酸無水物、ポリオルソエステル、ポリカーボネート、ポリホスファゼン、ポリリン酸エステル、ポリビニルアルコール、ポリペプチド、多糖、タンパク質、セルロースからなる群から選択される重合体、ならびに前記重合体を構成する一以上の単量体から構成される共重合体からなる群より選択される少なくとも一種の生分解性樹脂を含むことが好ましい。
図1は、本発明の一実施形態に係る医療器具を構成する生分解性シートの平面図である。図2は、図1に示す2−2線に沿った断面図である。図3は、複数の貫通孔のサイズを説明するための拡大説明図である。
本発明に係る医療器具を構成する生分解性シートには、癒合を促進するための癒合強化剤が配合されていてもよい。癒合強化剤としては、胸膜癒着術で癒着作用を示す材料であれば特に制限なく用いられうる。例えば、タルク、ポビドンヨード(イソジンなど)、硬化剤(ミノサイクリン、テトラサイクリンなど)、抗がん剤(アドリアマイシン,マイトマイシンC,シスプラチンなど)、免疫賦活剤(OK−432、Broncasma Bernaなど)が挙げられる。タルク、ポビドンヨード、硬化剤および抗がん剤は、胸膜腔内に投与すると化学作用によって炎症を惹起し、回復過程において癒着を生じさせる。また、免疫賦活剤は、死菌製剤へのアレルギー反応によって胸膜からフィブリン析出を促進して、癒着を促進する。
本発明にかかる生分解性シートの製造方法について特に制限はなく、上述した特徴的なサイズを有する貫通孔が形成された生分解性樹脂等からなるシートを製造することが可能な任意の方法が採用されうる。
本発明に係る医療器具(生分解性シート)は、生体組織の癒合を促進するのに用いられる癒合促進デバイスとして用いられうる。
図4には、変形例1に係る医療器具110(生分解性シート120)を示す。
図5には、変形例2に係る医療器具210(生分解性シート220)の拡大断面図(図2に相当する断面図)を示す。
図6には、変形例3に係る医療器具310(生分解性シート320)の拡大断面図(図2に相当する断面図)を示す。
図7には、変形例4に係る医療器具410(生分解性シート420)の概観斜視図を示す。
図8には、変形例5に係る医療器具510(生分解性シート520)の概観斜視図を示す。
図9には、変形例6に係る医療器具610(生分解性シート620)の概観斜視図を示す。
図10には、変形例7に係る医療器具710の概観斜視図を示す。
図11には、変形例8に係る医療器具810の概観斜視図を示す。
図1および図2に示すような、多数の貫通孔が形成された生分解性シート(癒合促進デバイス)を、エレクトロスピニング法により形成した生分解性樹脂シートにレーザー光を照射することにより製造した。ここで、得られた生分解性シート(癒合促進デバイス)に設けられた多数の貫通孔の孔径(D)、ピッチ(P)、孔径/ピッチ比(D/P)および厚み(T)の値を下記の表1に示す。
グレード1:わずかな鈍的操作で組織損傷なしに剥離可能な癒着
グレード2:鈍的操作で組織損傷なしに剥離可能な癒着
グレード3:鈍的操作で組織損傷を伴いながら剥離可能な癒着
グレード4:強い鈍的操作で組織損傷を伴いながら剥離可能な癒着
グレード5:強い鈍的操作でも剥離できない癒着
図1および図2に示すような、多数の貫通孔が形成された生分解性シート(癒合促進デバイス)を、2種類の製法を用いて製造した。1つ目は、樹脂溶液に癒合強化剤を溶解、または懸濁した状態でエレクトロスピニング法により形成した生分解性樹脂シートにプレス孔加工を施す方法(以下、「混練法」とも称する)により製造した。2つ目は、樹脂溶液のみでエレクトロスピニング法により形成した生分解性樹脂シートにプレス孔加工した後、癒合強化剤の溶液に浸漬し、乾燥して生分解性シートに癒合強化剤を吸着させる方法(以下、「吸着法」とも称する)により製造した。
20、120、220、320、420、520、620、720、820 生分解性シート、
21 一方の面、
23 他方の面、
25 側面(一辺)、
30 貫通孔、
31 連通孔、
230a 狭小部、
330a 幅広部、
440 中心孔、
550 スリット、
620a 生分解性シートの本体部、
660 突出部、
D 貫通孔の孔径、
P 貫通孔のピッチ、
T 生分解性シートの厚み。
Claims (12)
- 複数の貫通孔が形成された生分解性シートを備える医療器具であって、
前記貫通孔のピッチPに対する孔径Dの比の値(D/P)が0.25以上40未満である、医療器具。 - 前記孔径Dが0.1〜6mmである、請求項1に記載の医療器具。
- 前記ピッチPが0.1〜0.4mmである、請求項1または2に記載の医療器具。
- 前記生分解性シートの厚みが0.1〜0.2mmである、請求項1〜3のいずれか1項に記載の医療器具。
- 前記貫通孔が前記生分解性シートの厚み方向に沿って略垂直に設けられている、請求項1〜4のいずれか1項に記載の医療器具。
- 前記貫通孔は、前記生分解性シートの厚み方向と交差する方向に一部が広がる形状を有する、請求項1〜5のいずれか1項に記載の医療器具。
- 前記生分解性シートは、平面視において円形形状を有しており、
前記平面視した際の略中心位置に、前記貫通孔よりも孔径が大きく形成された中心孔が形成されている、請求項1〜6のいずれか1項に記載の医療器具。 - 前記生分解性シートの側面と前記中心孔とに連なるスリットを有する請求項7に記載の医療器具。
- 前記生分解性シートは、平面視において略矩形形状に形成された本体部を有しており、
前記本体部の一辺には、前記本体部から突出した突起部が形成されている、請求項1〜6のいずれか1項に記載の医療器具。 - 前記生分解性シートの構成材料は、ポリ乳酸(PLA)、ポリグリコール酸(PGA)または乳酸−グリコール酸共重合体(PLGA)である、請求項1〜9のいずれか1項に記載の医療器具。
- 前記生分解性シートに癒合強化剤が配合されてなる、請求項1〜10のいずれか1項に記載の医療器具。
- 生体組織の癒合を促進するのに用いられる癒合促進デバイスである、請求項1〜11のいずれか1項に記載の医療器具。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023060201A JP2023080155A (ja) | 2018-02-08 | 2023-04-03 | 癒合促進デバイス |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018021171 | 2018-02-08 | ||
JP2018021171 | 2018-02-08 | ||
PCT/JP2019/004690 WO2019156230A1 (ja) | 2018-02-08 | 2019-02-08 | 医療器具およびこれを用いた癒合促進デバイス |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023060201A Division JP2023080155A (ja) | 2018-02-08 | 2023-04-03 | 癒合促進デバイス |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2019156230A1 true JPWO2019156230A1 (ja) | 2021-03-18 |
JP7257342B2 JP7257342B2 (ja) | 2023-04-13 |
Family
ID=67549453
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019571175A Active JP7257342B2 (ja) | 2018-02-08 | 2019-02-08 | 医療器具およびこれを用いた癒合促進デバイス |
JP2023060201A Pending JP2023080155A (ja) | 2018-02-08 | 2023-04-03 | 癒合促進デバイス |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023060201A Pending JP2023080155A (ja) | 2018-02-08 | 2023-04-03 | 癒合促進デバイス |
Country Status (5)
Country | Link |
---|---|
US (1) | US11944283B2 (ja) |
EP (1) | EP3750487A4 (ja) |
JP (2) | JP7257342B2 (ja) |
CN (1) | CN111655171B (ja) |
WO (1) | WO2019156230A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112638287A (zh) * | 2018-09-27 | 2021-04-09 | 泰尔茂株式会社 | 愈合促进器具以及医疗设备 |
EP3932333A4 (en) * | 2019-03-28 | 2022-04-27 | TERUMO Kabushiki Kaisha | GRIP PROMOTING DEVICE |
JP7498188B2 (ja) | 2019-09-25 | 2024-06-11 | テルモ株式会社 | 癒合促進デバイス |
WO2021065896A1 (ja) * | 2019-09-30 | 2021-04-08 | テルモ株式会社 | 医療器具及び医療器具セット |
CZ309650B6 (cs) * | 2021-05-25 | 2023-06-14 | CSc. Ferko Alexander prof. MUDr. | Implantát |
JPWO2023032693A1 (ja) * | 2021-09-03 | 2023-03-09 | ||
WO2023032692A1 (ja) | 2021-09-03 | 2023-03-09 | テルモ株式会社 | 医療用部材 |
EP4393414A1 (en) | 2021-09-27 | 2024-07-03 | TERUMO Kabushiki Kaisha | Medical device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516669A (ja) * | 2004-10-15 | 2008-05-22 | タイコ ヘルスケア グループ エルピー | 吻合のためのシール要素 |
JP2011015966A (ja) * | 2009-07-08 | 2011-01-27 | Tyco Healthcare Group Lp | 外科用ガスケット |
US20110288568A1 (en) * | 2008-12-19 | 2011-11-24 | Capuzziello Thomas J | Implantable prosthesis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01274750A (ja) * | 1988-04-28 | 1989-11-02 | Yoshifumi Sera | 刺入針リング式臓器、消化管吻合器 |
IT1318499B1 (it) * | 2000-05-05 | 2003-08-25 | Angiologica B M S R L | Rete anatomica a doppio strato per chirurgia. |
US6767972B1 (en) | 2000-09-15 | 2004-07-27 | Eastman Chemical Company | Methods for slowing the degradation rate of biodegradable polymers and biodegradable polymer compositions and compositions thereof |
US7547312B2 (en) * | 2003-09-17 | 2009-06-16 | Gore Enterprise Holdings, Inc. | Circular stapler buttress |
MX344532B (es) | 2004-10-01 | 2016-12-19 | Ramscor Inc | Composiciones de farmaco de liberacion sostenida convenientemente implantables. |
US7922743B2 (en) * | 2004-10-18 | 2011-04-12 | Tyco Healthcare Group Lp | Structure for applying sprayable wound treatment material |
US7938307B2 (en) | 2004-10-18 | 2011-05-10 | Tyco Healthcare Group Lp | Support structures and methods of using the same |
US20070203510A1 (en) * | 2006-02-28 | 2007-08-30 | Bettuchi Michael J | Annular disk for reduction of anastomotic tension and methods of using the same |
US20090216338A1 (en) * | 2005-09-12 | 2009-08-27 | Peter Gingras | Soft tissue implants and methods for making same |
EP1955643B1 (en) * | 2005-12-01 | 2019-01-09 | Olympus Corporation | Guiding long medical member and long medical device |
AU2007265987B2 (en) | 2006-06-30 | 2012-11-08 | Kyoto University | Thin film multilocular structure comprising collagen, material for tissue regeneration containing the same and method for producing the same |
US20090069904A1 (en) | 2007-09-12 | 2009-03-12 | Applied Medical Research | Biomaterial including micropores |
US8629314B2 (en) | 2007-12-18 | 2014-01-14 | Ethicon, Inc. | Surgical barriers having adhesion inhibiting properties |
US8299316B2 (en) * | 2007-12-18 | 2012-10-30 | Ethicon, Inc. | Hemostatic device |
CA2946195A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
EP2349075A2 (en) * | 2008-11-07 | 2011-08-03 | Sofradim Production | Medical device including a bacterial cellulose sheet, perforated or microperforated as a mesh |
EP2395941B1 (en) | 2009-02-11 | 2017-01-11 | Nanyang Technological University | Multi-layered surgical prosthesis |
US8784294B2 (en) * | 2009-06-03 | 2014-07-22 | Boston Scientific Scimed, Inc. | Synthetic graft for soft tissue repair |
WO2013119859A1 (en) * | 2012-02-08 | 2013-08-15 | Boston Scientific Scimed, Inc. | Porous surgical films |
US20150351753A1 (en) | 2014-06-10 | 2015-12-10 | Ethicon Endo-Surgery, Inc. | Methods and Devices for Reinforcing a Staple Line |
CN107155296B (zh) * | 2014-06-10 | 2020-07-14 | 伊西康内外科有限责任公司 | 用于密封组织中的钉的装置 |
JP6567590B2 (ja) | 2016-07-25 | 2019-08-28 | 日東電工株式会社 | ミリ波アンテナ用フィルム |
IT201600082538A1 (it) | 2016-08-04 | 2018-02-04 | Univ Degli Studi Di Torino | Sistema multifunzionale per il rinforzo di linee di sutura a mano o meccaniche e la prevenzione della deiscenza in siti anastomotici. |
JP2018202003A (ja) | 2017-06-07 | 2018-12-27 | グンゼ株式会社 | 吻合補綴材 |
AU2019361136A1 (en) | 2018-10-19 | 2021-05-27 | Nova Southeastern University | Sublingual epinephrine compositions including pH-modifying excipients and penetration enhancers and methods for use thereof |
-
2019
- 2019-02-08 CN CN201980010657.7A patent/CN111655171B/zh active Active
- 2019-02-08 WO PCT/JP2019/004690 patent/WO2019156230A1/ja active Search and Examination
- 2019-02-08 JP JP2019571175A patent/JP7257342B2/ja active Active
- 2019-02-08 EP EP19750339.4A patent/EP3750487A4/en active Pending
-
2020
- 2020-08-07 US US16/987,897 patent/US11944283B2/en active Active
-
2023
- 2023-04-03 JP JP2023060201A patent/JP2023080155A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516669A (ja) * | 2004-10-15 | 2008-05-22 | タイコ ヘルスケア グループ エルピー | 吻合のためのシール要素 |
US20110288568A1 (en) * | 2008-12-19 | 2011-11-24 | Capuzziello Thomas J | Implantable prosthesis |
JP2011015966A (ja) * | 2009-07-08 | 2011-01-27 | Tyco Healthcare Group Lp | 外科用ガスケット |
Also Published As
Publication number | Publication date |
---|---|
JP7257342B2 (ja) | 2023-04-13 |
US20200360002A1 (en) | 2020-11-19 |
EP3750487A1 (en) | 2020-12-16 |
JP2023080155A (ja) | 2023-06-08 |
EP3750487A4 (en) | 2020-12-16 |
CN111655171A (zh) | 2020-09-11 |
CN111655171B (zh) | 2024-03-08 |
WO2019156230A1 (ja) | 2019-08-15 |
US11944283B2 (en) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7257342B2 (ja) | 医療器具およびこれを用いた癒合促進デバイス | |
US11596402B2 (en) | Adjunct materials and methods of using same in surgical methods for tissue sealing | |
AU2017200682B2 (en) | Methods and devices for soft palate tissue elevation procedures | |
KR101577602B1 (ko) | 이-방향성 유지장치 또는 단일-방향성 유지장치를 갖는 자가-유지 봉합사 | |
JP5693260B2 (ja) | 外科手術用メッシュ | |
KR100876516B1 (ko) | 흡수성 혈관문합 장치 | |
KR101851119B1 (ko) | 자가-유지형 봉합재를 위한 표면 텍스처 구성 및 이를 형성하기 위한 방법 | |
US6685956B2 (en) | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications | |
WO2013089493A1 (ko) | 유착방지용 조성물, 이를 포함하는 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법 | |
CN110951061B (zh) | 可生物降解的三嵌段共聚物和由其制成的可植入医疗装置 | |
JP2010540003A (ja) | 治癒中の瘢痕組織を減ずるための再吸収性障壁微小膜 | |
Ikada | Bioabsorbable fibers for medical use | |
KR101748551B1 (ko) | 형상기억 고분자 마이크로니들 혈관 문합 장치 | |
KR101275262B1 (ko) | 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법 | |
Tsai et al. | The degradation and biocompatible study of polyester film in the gastrointestinal tract | |
JP2012040360A (ja) | 表面腐食性縫合糸 | |
NZ617993B2 (en) | Methods and devices for soft palate tissue elevation procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20200604 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211015 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221104 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230307 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230403 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7257342 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |